<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Index</ArticleTitle>
<VernacularTitle>Index</VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">14800</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Click to download the index of this issue.</Abstract>
			<OtherAbstract Language="FA">Click to download the index of this issue.</OtherAbstract>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14800_6c2de35b691097827da9fdaadc060d69.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Epidemiology and Trend of Incidence of the Leukemia in Iran</ArticleTitle>
<VernacularTitle>Epidemiology and Trend of Incidence of the Leukemia in Iran</VernacularTitle>
			<FirstPage>2055</FirstPage>
			<LastPage>2061</LastPage>
			<ELocationID EIdType="pii">14801</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Koohi</LastName>
<Affiliation>MSc Student, Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mahshid</FirstName>
					<LastName>Ghoncheh</LastName>
<Affiliation>MSc Student, Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hamid</FirstName>
					<LastName>Salehiniya</LastName>
<Affiliation>Epidemiologist, Minimally Invasive Surgery Research Center, Iran University of Medical Sciences AND Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>07</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>Background: Leukemia makes up about 8% of all cancers. Understanding the epidemiology of leukemia is very effective in planning for this cancer. According to lack of information in the field, the present study aimed to investigate the epidemiology and trend of incidence of leukemia in Iran during 2003 to 2010.Methods: This cross-sectional study was conducted using the analysis data from the Iranian National Cancer Registration System and Disease Management Center, Ministry of Health and Medical Education during the years 2003 to 2010. The incidence rates were calculated by age and gender and the trend of incidence of the disease by sex during this period was achieved.Findings: Evaluation of cancer registration data in the years 2003 to 2010 showed the ascending trend of leukemia in Iran. 21814 cases of leukemia were recorded in the whole country that increased from 1734 cases in 2003 to 3461 cases in 2010. The highest and the lowest incidence in women and men were reported in years 2009 and 2003, respectively. In the provinces of country, the highest reported incidence in women was in Yazd and the lowest incidence was in Semnan, Kermanshah, Qom and Kohgiluyeh and Boyer Ahmad; and for men, the highest incidence was in Yazd and the lowest incidence was in Zanjan, North and South Khorasan, Semnan, Ardebil and Kohgiluyeh and Boyer Ahmad. The sex ratio of male to female was 1.64.Conclusion: Based on the results, the incidence of leukemia in Iran is rising. Although a proportion of this increase may be due to improvements in cancer registration system but the probability of increase of incidence of leukemia exists because of the associated risk factors. Thus, the identification of the risk factors in different regions of Iran to prevent and to detect the disease at an early stage in recommended for disease control.</Abstract>
			<OtherAbstract Language="FA">Background: Leukemia makes up about 8% of all cancers. Understanding the epidemiology of leukemia is very effective in planning for this cancer. According to lack of information in the field, the present study aimed to investigate the epidemiology and trend of incidence of leukemia in Iran during 2003 to 2010.Methods: This cross-sectional study was conducted using the analysis data from the Iranian National Cancer Registration System and Disease Management Center, Ministry of Health and Medical Education during the years 2003 to 2010. The incidence rates were calculated by age and gender and the trend of incidence of the disease by sex during this period was achieved.Findings: Evaluation of cancer registration data in the years 2003 to 2010 showed the ascending trend of leukemia in Iran. 21814 cases of leukemia were recorded in the whole country that increased from 1734 cases in 2003 to 3461 cases in 2010. The highest and the lowest incidence in women and men were reported in years 2009 and 2003, respectively. In the provinces of country, the highest reported incidence in women was in Yazd and the lowest incidence was in Semnan, Kermanshah, Qom and Kohgiluyeh and Boyer Ahmad; and for men, the highest incidence was in Yazd and the lowest incidence was in Zanjan, North and South Khorasan, Semnan, Ardebil and Kohgiluyeh and Boyer Ahmad. The sex ratio of male to female was 1.64.Conclusion: Based on the results, the incidence of leukemia in Iran is rising. Although a proportion of this increase may be due to improvements in cancer registration system but the probability of increase of incidence of leukemia exists because of the associated risk factors. Thus, the identification of the risk factors in different regions of Iran to prevent and to detect the disease at an early stage in recommended for disease control.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Leukemia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Epidemiology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Incidence</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Trends</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14801_209dc878267a1292ff2a1b0bdfbbc52e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Effect of Pre-, Intra- and Postoperative Blood Glucose on Outcomes of Patients with Traumatic Brain Injury</ArticleTitle>
<VernacularTitle>The Effect of Pre-, Intra- and Postoperative Blood Glucose on Outcomes of Patients with Traumatic Brain Injury</VernacularTitle>
			<FirstPage>2062</FirstPage>
			<LastPage>2069</LastPage>
			<ELocationID EIdType="pii">14802</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Reyhanak</FirstName>
					<LastName>Talakoub</LastName>
<Affiliation>Associate Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Golparvar</LastName>
<Affiliation>Associate Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Elham</FirstName>
					<LastName>Khodadoustan</LastName>
<Affiliation>Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>08</Month>
					<Day>09</Day>
				</PubDate>
			</History>
		<Abstract>Background: Traumatic brain injury is one of the important problems of world health with high mortality; probably, simultaneous hyperglycemia can intensify the harmful effects. Since there is no unique opinion in this regard, we aimed to study the effect of blood glucose at before, during and after operation on outcome of patients with traumatic brain injury.Methods: A hundred patients with traumatic brain injury were studied during a prospective clinical trial study. We divided patients according to their preoperative blood glucose level to two groups of normo- and hyperglycemic. We measured and recorded blood glucose level during and after operation, in addition to the heart rate, blood pressure, saturation of oxygen (SpO2), duration of mechanical ventilation and outcome of patients in both groups.Findings: Heart rate was significantly higher at 15th (P = 0.027), 60th (P = 0.018), 105th (P = 0.010) minutes and in recovery room (P = 0.006) in hyperglycemic patients; but as a general, the changes in heart rates were not significant in both groups (P = 0.610). There was no difference in SpO2 at different times. The mean arterial pressure (MAP) was higher at 45th (P = 0.025) and 60th (P = 0.016) minutes during the surgery; but as a general, there were no significant difference in MAP between the two groups (P = 0.850). Duration of mechanical ventilation was significantly longer in hyperglycemic patients (P = 0.009).Conclusion: According to our findings, elevated blood glucose patients with traumatic brain injury may results in some intraoperative hemodynamic changes and affect their outcome. Therefore, monitoring of blood glucose in these patients is suggested.</Abstract>
			<OtherAbstract Language="FA">Background: Traumatic brain injury is one of the important problems of world health with high mortality; probably, simultaneous hyperglycemia can intensify the harmful effects. Since there is no unique opinion in this regard, we aimed to study the effect of blood glucose at before, during and after operation on outcome of patients with traumatic brain injury.Methods: A hundred patients with traumatic brain injury were studied during a prospective clinical trial study. We divided patients according to their preoperative blood glucose level to two groups of normo- and hyperglycemic. We measured and recorded blood glucose level during and after operation, in addition to the heart rate, blood pressure, saturation of oxygen (SpO2), duration of mechanical ventilation and outcome of patients in both groups.Findings: Heart rate was significantly higher at 15th (P = 0.027), 60th (P = 0.018), 105th (P = 0.010) minutes and in recovery room (P = 0.006) in hyperglycemic patients; but as a general, the changes in heart rates were not significant in both groups (P = 0.610). There was no difference in SpO2 at different times. The mean arterial pressure (MAP) was higher at 45th (P = 0.025) and 60th (P = 0.016) minutes during the surgery; but as a general, there were no significant difference in MAP between the two groups (P = 0.850). Duration of mechanical ventilation was significantly longer in hyperglycemic patients (P = 0.009).Conclusion: According to our findings, elevated blood glucose patients with traumatic brain injury may results in some intraoperative hemodynamic changes and affect their outcome. Therefore, monitoring of blood glucose in these patients is suggested.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Blood glucose</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Brain injury</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hemodynamic changes</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Outcome</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14802_29ddf7414ac131a83205fe7195aff159.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of the 3-Year Survival Rate in Patients with all Kinds of Glioma Tumors in Alzahra Hospital, Isfahan, Iran, 2001-2010</ArticleTitle>
<VernacularTitle>Evaluation of the 3-Year Survival Rate in Patients with all Kinds of Glioma Tumors in Alzahra Hospital, Isfahan, Iran, 2001-2010</VernacularTitle>
			<FirstPage>2070</FirstPage>
			<LastPage>2075</LastPage>
			<ELocationID EIdType="pii">14803</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Bahram</FirstName>
					<LastName>Amin-Manour</LastName>
<Affiliation>Professor, Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Masih</FirstName>
					<LastName>Rezaei</LastName>
<Affiliation>Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>08</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Background: Glioma is a type of brain tumor that occurs in the brain and spinal cord and is derived from glial cells. Frequency, survival and response to therapy in these tumors are dependent on age and sex. The survival rate varies from several months to years. In the current study, 3-year survival rate in patients with all kinds of glioma tumors who were hospitalized in Alzahra hospital, Isfahan, Iran, in the years 2001-2010 were evaluated.Methods: In the current study, the target population was the patients with all kinds of proven glioma who had resection surgery. The volume of the population was determined as all the patients with all kinds of glioma tumors in the years 2001-2010, who were operated in Alzahra hospital. The total number of patients was 490. Inclusion criteria were patient’s tendency for participation in the study, the accuracy of the patient’s basic information in the archive documents and lack of death at the hospital, in pre-, intra- and postoperation periods. According to these criteria, only 221 were eligible for inclusion. The information such as name, family, age, gender, tumor type, treatment type and telephone number were extracted from the list of the patients. The patients were contacted and questionnaires were completed. Microsoft Excel software was used for data analysis, so that its data were the number of people with any type of tumor, age, sex of the patients and the three-year survival rate of any tumor.Findings: The three-year survival was 8.7% in glioblastoma multiform, 100% in diffuse astrocytoma, epondymoma and pilocytic astrocytoma, 95.2% in oligodandroglioma, and zero in anaplastic astrocytoma.Conclusion: In this study, surgery plus radiotherapy in diffuse astrocytoma, oligodandroglioma and epondymoma increased three-year survival rate. In pilocytic astrocytoma surgery, as the first treatment, increased the three-year survival. In the case of glioblastoma multiform and anaplastic astrocytoma, surgery plus radiotherapy with or without chemotherapy briefly play role in increasing the survival rate.</Abstract>
			<OtherAbstract Language="FA">Background: Glioma is a type of brain tumor that occurs in the brain and spinal cord and is derived from glial cells. Frequency, survival and response to therapy in these tumors are dependent on age and sex. The survival rate varies from several months to years. In the current study, 3-year survival rate in patients with all kinds of glioma tumors who were hospitalized in Alzahra hospital, Isfahan, Iran, in the years 2001-2010 were evaluated.Methods: In the current study, the target population was the patients with all kinds of proven glioma who had resection surgery. The volume of the population was determined as all the patients with all kinds of glioma tumors in the years 2001-2010, who were operated in Alzahra hospital. The total number of patients was 490. Inclusion criteria were patient’s tendency for participation in the study, the accuracy of the patient’s basic information in the archive documents and lack of death at the hospital, in pre-, intra- and postoperation periods. According to these criteria, only 221 were eligible for inclusion. The information such as name, family, age, gender, tumor type, treatment type and telephone number were extracted from the list of the patients. The patients were contacted and questionnaires were completed. Microsoft Excel software was used for data analysis, so that its data were the number of people with any type of tumor, age, sex of the patients and the three-year survival rate of any tumor.Findings: The three-year survival was 8.7% in glioblastoma multiform, 100% in diffuse astrocytoma, epondymoma and pilocytic astrocytoma, 95.2% in oligodandroglioma, and zero in anaplastic astrocytoma.Conclusion: In this study, surgery plus radiotherapy in diffuse astrocytoma, oligodandroglioma and epondymoma increased three-year survival rate. In pilocytic astrocytoma surgery, as the first treatment, increased the three-year survival. In the case of glioblastoma multiform and anaplastic astrocytoma, surgery plus radiotherapy with or without chemotherapy briefly play role in increasing the survival rate.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Survival Rate</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Glioma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tumor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Iran</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14803_7ce96e616cfd1a5caa4127a0ce4bd7fd.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparing the Effects of Magnesium Sulfate and Nitroglycerin on the Control of Hypertension during and after Cataract Surgery under Local Anesthesia and Intravenous Sedation</ArticleTitle>
<VernacularTitle>Comparing the Effects of Magnesium Sulfate and Nitroglycerin on the Control of Hypertension during and after Cataract Surgery under Local Anesthesia and Intravenous Sedation</VernacularTitle>
			<FirstPage>2076</FirstPage>
			<LastPage>2083</LastPage>
			<ELocationID EIdType="pii">14804</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mojtaba</FirstName>
					<LastName>Rahimi</LastName>
<Affiliation>Associate Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7725-9393</Identifier>

</Author>
<Author>
					<FirstName>Kamran</FirstName>
					<LastName>Montazeri</LastName>
<Affiliation>Associate Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Leyla</FirstName>
					<LastName>Kamali</LastName>
<Affiliation>Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Daryoush</FirstName>
					<LastName>Moradi</LastName>
<Affiliation>Assistant Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Khosrou</FirstName>
					<LastName>Naghibi</LastName>
<Affiliation>Associate Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0577-6989</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>08</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>Background: Most of the patients undergoing cataract surgery are middle-aged and older ones, accompanying high prevalence of hypertension that needs control. We compared antihypertensive effects of magnesium sulfate, as an effective drug in blood pressure control with that’s of nitroglycerine and placebo.Methods: 105 patients were allocated with simple randomization in 3 groups of 35; group 1 received stat infusion of magnesium sulfate with a dose of 30 mg/kg during 5 minutes which continued with the dose of 1 mg/kg/minute until the end of surgery; group 2 received stat infusion of nitroglycerin with the dose of 1 µg/kg during 5 minutes which continued with the dose of 0.05 µg/kg/minute; and group 3 received the solution of dextrose 5% as placebo infused with the same volume and the same infusion rate. All the groups received intravenous (IV) sedation using midazolam 0.02-0.03 mg/kg and fentanyl 1-2 µg/kg with eye drop local anesthetic tetracaine 0.5% and undergone phacoemulsification cataract surgery. Hemodynamic parameters during operation, in recovery and at the ward entrance and exit time were recorded.Findings: There was no significant difference between the mean diastolic blood pressure among all the groups (P = 0.49). The mean systolic and mean arterial (MAP) blood pressures during the operation at the 30th minute, and then at 15th and 30th minutes in recovery and also at the ward entry and exit time, had lower amounts in magnesium sulfate and nitroglycerin groups compared to placebo group (P = 0.019). But, there was no significant difference between the magnesium sulfate and nitroglycerin groups (P = 0.060). The mean heart rate was not significantly different at any of the studied times among 3 groups (P = 0.170).Conclusion: The usage of magnesium sulfate in patients with hypertension is effective during and especially after phacoemulsification surgery cataract under local anesthesia just like nitroglycerine; but has no significant effect on the postoperative pain.</Abstract>
			<OtherAbstract Language="FA">Background: Most of the patients undergoing cataract surgery are middle-aged and older ones, accompanying high prevalence of hypertension that needs control. We compared antihypertensive effects of magnesium sulfate, as an effective drug in blood pressure control with that’s of nitroglycerine and placebo.Methods: 105 patients were allocated with simple randomization in 3 groups of 35; group 1 received stat infusion of magnesium sulfate with a dose of 30 mg/kg during 5 minutes which continued with the dose of 1 mg/kg/minute until the end of surgery; group 2 received stat infusion of nitroglycerin with the dose of 1 µg/kg during 5 minutes which continued with the dose of 0.05 µg/kg/minute; and group 3 received the solution of dextrose 5% as placebo infused with the same volume and the same infusion rate. All the groups received intravenous (IV) sedation using midazolam 0.02-0.03 mg/kg and fentanyl 1-2 µg/kg with eye drop local anesthetic tetracaine 0.5% and undergone phacoemulsification cataract surgery. Hemodynamic parameters during operation, in recovery and at the ward entrance and exit time were recorded.Findings: There was no significant difference between the mean diastolic blood pressure among all the groups (P = 0.49). The mean systolic and mean arterial (MAP) blood pressures during the operation at the 30th minute, and then at 15th and 30th minutes in recovery and also at the ward entry and exit time, had lower amounts in magnesium sulfate and nitroglycerin groups compared to placebo group (P = 0.019). But, there was no significant difference between the magnesium sulfate and nitroglycerin groups (P = 0.060). The mean heart rate was not significantly different at any of the studied times among 3 groups (P = 0.170).Conclusion: The usage of magnesium sulfate in patients with hypertension is effective during and especially after phacoemulsification surgery cataract under local anesthesia just like nitroglycerine; but has no significant effect on the postoperative pain.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Magnesium sulfate</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nitroglycerine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Phacoemulsification</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hypertension</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14804_67738a8ef0ab585533cf0dba3b58eee9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Fabrication and Evaluation of Cell-Compatibility and in-Vitro Biodegradation of PGS/CaTiO3 Composite for Nerve Conduit Application</ArticleTitle>
<VernacularTitle>Fabrication and Evaluation of Cell-Compatibility and in-Vitro Biodegradation of PGS/CaTiO3 Composite for Nerve Conduit Application</VernacularTitle>
			<FirstPage>2084</FirstPage>
			<LastPage>2091</LastPage>
			<ELocationID EIdType="pii">14805</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Naser</LastName>
<Affiliation>MSc Student, Department of Biomedical Engineering and Biomaterials, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Anousheh</FirstName>
					<LastName>Zargar-Kharazi</LastName>
<Affiliation>Assistant Professor, Department of Biomaterials, Tissue Engineering and Medical Nanotechnology, School of Advanced Medical Technology, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8945-0144</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>08</Month>
					<Day>06</Day>
				</PubDate>
			</History>
		<Abstract>Background: Poly(glycerol sebacate) (PGS) is a novel biological polymer for biomedical application with high biocompatibility, mechanical properties near to soft tissues of body and a adaptability of properties during synthesis. But, this polymer tends to undergo rather rapid biodegradation which is usually faster than peripheral nerve regeneration and needs optimization of degradability properties for using as a nerve conduit.Methods: First, PGS pre-polymer was synthesized and then, equal to 5% of its weight, calcium titanate ceramic, which is highly biocompatible, was added to it and the acquired mixture was exposed to heat in vacuum oven to increase its strength. The obtained biocomposite came under scanning electron microscopy (SEM) image, Fourier transform infrared (FTIR) spectroscopy, in-vitro biodegradation and cytotoxicity evaluation.Findings: A composite with high particle distribution was obtained which represented a chemical bond between its two precursors. The in-vitro degradation time showed 23% reduction in overall weight loss for the composite in comparison to pure PGS over a period of 60 days degradation. The cell culture showed more than 90% of viability after 5 days of culture for the composite.Conclusion: Regarding to biodegradation rate, molecular mass and high cytocompatibility, this composite is encouraging enough to merit further investigation for nerve conduit application.</Abstract>
			<OtherAbstract Language="FA">Background: Poly(glycerol sebacate) (PGS) is a novel biological polymer for biomedical application with high biocompatibility, mechanical properties near to soft tissues of body and a adaptability of properties during synthesis. But, this polymer tends to undergo rather rapid biodegradation which is usually faster than peripheral nerve regeneration and needs optimization of degradability properties for using as a nerve conduit.Methods: First, PGS pre-polymer was synthesized and then, equal to 5% of its weight, calcium titanate ceramic, which is highly biocompatible, was added to it and the acquired mixture was exposed to heat in vacuum oven to increase its strength. The obtained biocomposite came under scanning electron microscopy (SEM) image, Fourier transform infrared (FTIR) spectroscopy, in-vitro biodegradation and cytotoxicity evaluation.Findings: A composite with high particle distribution was obtained which represented a chemical bond between its two precursors. The in-vitro degradation time showed 23% reduction in overall weight loss for the composite in comparison to pure PGS over a period of 60 days degradation. The cell culture showed more than 90% of viability after 5 days of culture for the composite.Conclusion: Regarding to biodegradation rate, molecular mass and high cytocompatibility, this composite is encouraging enough to merit further investigation for nerve conduit application.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Poly(glycerol sebacate)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Biocomposite</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Calcium titanate</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14805_ce2f2c502e5d4a00b8909503dad1d127.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Relationship between the Genetic Polymorphisms of Interleukin-33 (IL-33) and Interleukin-1 Receptor-Like 1 (IL1R1) with the Levels of Interleukin-33 in Patients with Asthma and Multiple Sclerosis</ArticleTitle>
<VernacularTitle>The Relationship between the Genetic Polymorphisms of Interleukin-33 (IL-33) and Interleukin-1 Receptor-Like 1 (IL1R1) with the Levels of Interleukin-33 in Patients with Asthma and Multiple Sclerosis</VernacularTitle>
			<FirstPage>2092</FirstPage>
			<LastPage>2101</LastPage>
			<ELocationID EIdType="pii">14806</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Ahmadi</LastName>
<Affiliation>MSc Student, Department of Immunology, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Nahid</FirstName>
					<LastName>Eskandari</LastName>
<Affiliation>Assistant Professor, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1910-9359</Identifier>

</Author>
<Author>
					<FirstName>Fereshteh</FirstName>
					<LastName>Ale-Sahebfosoul</LastName>
<Affiliation>Assistant Professor, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mansour</FirstName>
					<LastName>Salehi</LastName>
<Affiliation>Associate Professor, Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ramin</FirstName>
					<LastName>Ghasemi</LastName>
<Affiliation>Asthma and Allergy Specialist, Isfahan Asthma and Allergy Clinic, Isfahan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>Background: Recent evidence suggests that the interleukin-33/interleukin-1 receptor-like 1 (IL-33/IL1RL1) axis plays a critical role in autoimmune and inflammatory disorders; however, its mechanistic role in these diseases has not been clearly defined. The present study aimed to investigate the frequency of rs1342326 polymorphism of IL-33 gene and rs10204137 polymorphism of IL1RL1 gene with serum levels of IL-33 in multiple sclerosis (MS), asthma and healthy subjects In Isfahan Province, Iran.Methods: Samples were taken from the patients with asthma (140) or multiple sclerosis (140) and healthy controls (72). Different genotypes of T/G or G/A polymorphisms were studied using the high-resolution melting real-time polymerase chain reaction (HRM real-time PCR) technique. Serum levels of IL-33 were measured via enzyme-linked immunosorbent assay (ELISA). Findings: There was not any relationship between the frequency of polymorphism rs10204137 of IL1RL1 gene and susceptibility to multiple sclerosis or asthma. There was no significant correlation between the frequency of rs1342326 polymorphism of IL-33 gene in healthy subjects compared to those with asthma or multiple sclerosis. Serum levels of IL-33 were higher than in patients with multiple sclerosis or asthma compared to healthy subjects.Conclusion: Serum levels of IL-33 in the two groups of patient increased substantially compared to the controls.</Abstract>
			<OtherAbstract Language="FA">Background: Recent evidence suggests that the interleukin-33/interleukin-1 receptor-like 1 (IL-33/IL1RL1) axis plays a critical role in autoimmune and inflammatory disorders; however, its mechanistic role in these diseases has not been clearly defined. The present study aimed to investigate the frequency of rs1342326 polymorphism of IL-33 gene and rs10204137 polymorphism of IL1RL1 gene with serum levels of IL-33 in multiple sclerosis (MS), asthma and healthy subjects In Isfahan Province, Iran.Methods: Samples were taken from the patients with asthma (140) or multiple sclerosis (140) and healthy controls (72). Different genotypes of T/G or G/A polymorphisms were studied using the high-resolution melting real-time polymerase chain reaction (HRM real-time PCR) technique. Serum levels of IL-33 were measured via enzyme-linked immunosorbent assay (ELISA). Findings: There was not any relationship between the frequency of polymorphism rs10204137 of IL1RL1 gene and susceptibility to multiple sclerosis or asthma. There was no significant correlation between the frequency of rs1342326 polymorphism of IL-33 gene in healthy subjects compared to those with asthma or multiple sclerosis. Serum levels of IL-33 were higher than in patients with multiple sclerosis or asthma compared to healthy subjects.Conclusion: Serum levels of IL-33 in the two groups of patient increased substantially compared to the controls.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Interleukin-33 (IL-33)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Multiple Sclerosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Asthma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14806_da16089c5560ff14541029aceefc54de.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Isfahan Medical School</JournalTitle>
				<Issn>1027-7595</Issn>
				<Volume>33</Volume>
				<Issue>361</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Esophageal Rupture; A Case Report</ArticleTitle>
<VernacularTitle>Esophageal Rupture; A Case Report</VernacularTitle>
			<FirstPage>2102</FirstPage>
			<LastPage>2104</LastPage>
			<ELocationID EIdType="pii">14807</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mohammad Rahim</FirstName>
					<LastName>Vakili</LastName>
<Affiliation>Assistant Professor, Department of Surgery, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Bita</FirstName>
					<LastName>Shahbazzadegan</LastName>
<Affiliation>Department of Nursing, School of Medicine, Ardabil University of Medical Sciences, Ardabil AND PhD student, Department of Health Education and Health Promotion, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8151-9861</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Background: One of the most lethal damages of the gastrointestinal tract is esophageal perforation. The prevalent causes of esophageal perforation are diagnosis interventions, trauma, and Boerhaave’s syndrome. Although esophageal perforation after vomiting is rare, but has a high mortality risk; therefore, early diagnosis and treatment is essential.Case Report: The patient was a 44-year-old man admitted to the emergency room due to severe chest pain with a history of vomiting after eating egg, 4 hours ago. Vomiting was not too severe and the pain was in the right chest. After the diagnosis of esophageal rupture, the patient underwent thoracotomy.Conclusion: As esophageal perforation is a real emergency, on-time diagnosis and treatment is vital.</Abstract>
			<OtherAbstract Language="FA">Background: One of the most lethal damages of the gastrointestinal tract is esophageal perforation. The prevalent causes of esophageal perforation are diagnosis interventions, trauma, and Boerhaave’s syndrome. Although esophageal perforation after vomiting is rare, but has a high mortality risk; therefore, early diagnosis and treatment is essential.Case Report: The patient was a 44-year-old man admitted to the emergency room due to severe chest pain with a history of vomiting after eating egg, 4 hours ago. Vomiting was not too severe and the pain was in the right chest. After the diagnosis of esophageal rupture, the patient underwent thoracotomy.Conclusion: As esophageal perforation is a real emergency, on-time diagnosis and treatment is vital.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Esophageal rupture</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chest Pain</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Boerhaave’s syndrome</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jims.mui.ac.ir/article_14807_e240e7dde1c1a18499e136f075403f75.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
